Adage Capital Partners
NKGNW

Adage Capital Partners’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Adage Capital Partners’s Portfolio NKGNW Stock Details NKGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-159,266
Closed -$15.9K – 975
2024
Q4 		$15.9K Hold
159,266
– – ﹤0.01% 861
2024
Q3 		$11.3K Sell
159,266
-2,059
-1% -$184 ﹤0.01% 844
2024
Q2 		$14K Sell
161,325
-20,475
-11% -$2.14K ﹤0.01% 839
2024
Q1 		$29.1K Hold
181,800
– – ﹤0.01% 851
2023
Q4 		$14.7K Sell
181,800
-100
-0.1% -$13 ﹤0.01% 829
2023
Q3 		$71.8K Hold
181,900
– – ﹤0.01% 817
2023
Q2 		$36.4K Hold
181,900
– – ﹤0.01% 839
2023
Q1 		$25.5K Hold
181,900
– – ﹤0.01% 899
2022
Q4 		$15.4K Hold
181,900
– – ﹤0.01% 945
2022
Q3 		$27K Hold
181,900
– – ﹤0.01% 1007
2022
Q2 		$47K Hold
181,900
– – ﹤0.01% 1040
2022
Q1 		$110K Hold
181,900
– – ﹤0.01% 1049
2021
Q4 		$209K Hold
181,900
– – ﹤0.01% 985
2021
Q3 		$211K Buy
+181,900
New +$227K ﹤0.01% 982

Other funds holding NKGNW

RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return

Adage Capital Partners's NKGNW Position: Q1 2025 in Review

Adage Capital Partners sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q1 2025, closing a stake of 159,266 shares — an estimated $15.9K sold.

Adage Capital Partners first reported a position in NKGNW in Q3 2021 and held it in 14 quarters. The position peaked at $211K in Q3 2021. 3 funds tracked by Wall St. Rank hold NKGNW as of Q1 2025.

  • Adage Capital Partners reported no remaining NKGen Biotech, Inc. Warrants position as of Q1 2025 after selling out during the quarter.
  • Adage Capital Partners sold 159,266 NKGen Biotech, Inc. Warrants shares in Q1 2025, an estimated $15.9K.
  • Adage Capital Partners first reported a position in NKGen Biotech, Inc. Warrants in Q3 2021 and held it in 14 quarters.
  • Adage Capital Partners's NKGen Biotech, Inc. Warrants position peaked at $211K in Q3 2021.
  • 3 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q1 2025.

Based on Adage Capital Partners's 13F filing for Q1 2025, filed 15 May 2025.